Literature DB >> 2507775

Anti-ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide.

G J Grover1, J R McCullough, D E Henry, M L Conder, P G Sleph.   

Abstract

The direct cardioprotective efficacy of the potassium channel activators pinacidil and cromakalim was determined in isolated globally ischemic rat hearts. Isolated buffer-perfused rat hearts were subjected to 25 min of ischemia followed by 30 min of reperfusion. These hearts were pretreated with 1 to 100 microM pinacidil, 1 to 7 microM cromakalim or vehicle. Pinacidil resulted in significant improvements in reperfusion function and cardiac compliance, though it did not significantly reduce lactate dehydrogenase release at any concentration. The protective effects of pinacidil were greatest at a 10 microns concentration and were slightly diminished at higher concentrations (30 and 100 microns). Although not affecting the severity of ischemia alone, 10 microM glyburide (potassium channel blocker) completely reversed the protective effects of pinacidil on reperfusion function and compliance. Cromakalim (7 microM) resulted in a greater than 50% improvement in reperfusion function and compliance and unlike pinacidil significantly reduced lactate dehydrogenase release by approximately 50%. At 1 microM, glyburide alone did not significantly affect the severity of ischemia but reversed the protective effects of cromakalim. Not only did glyburide reverse the protective effects of cromakalim, it resulted in a worsening of ischemia compared to vehicle, an effect not seen with glyburide alone. Thus, both pinacidil and cromakalim appear to have direct cardioprotective efficacy, though some differences between them may be possible. The mechanism of their protective effects appears to be via potassium channel opening as the potassium channel blocker glyburide reverses the protective effect of these compounds. Intracellular electrophysiological studies showed that ischemia-induced depolarization was reversed with cromakalim, which increased the resting potential nearly back to preischemic levels.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2507775

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  31 in total

Review 1.  Physiology of potassium channels in the inner membrane of mitochondria.

Authors:  Ildikò Szabò; Luigi Leanza; Erich Gulbins; Mario Zoratti
Journal:  Pflugers Arch       Date:  2011-11-18       Impact factor: 3.657

Review 2.  KATP Channels in the Cardiovascular System.

Authors:  Monique N Foster; William A Coetzee
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

Review 3.  MitoKATP activity in healthy and ischemic hearts.

Authors:  Alexandre D T Costa; Keith D Garlid
Journal:  J Bioenerg Biomembr       Date:  2009-04       Impact factor: 2.945

Review 4.  Cardioprotective signaling to mitochondria.

Authors:  Keith D Garlid; Alexandre D T Costa; Casey L Quinlan; Sandrine V Pierre; Pierre Dos Santos
Journal:  J Mol Cell Cardiol       Date:  2008-12-11       Impact factor: 5.000

5.  Mitochondrial ATP-sensitive K+ channels, protectors of the heart.

Authors:  Mitsuhiko Yamada
Journal:  J Physiol       Date:  2010-01-15       Impact factor: 5.182

6.  KATP channel openers have opposite effects on mitochondrial respiration under different energetic conditions.

Authors:  Matthias L Riess; Amadou K S Camara; André Heinen; Janis T Eells; Michele M Henry; David F Stowe
Journal:  J Cardiovasc Pharmacol       Date:  2008-05       Impact factor: 3.105

Review 7.  Pinacidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension.

Authors:  H A Friedel; R N Brogden
Journal:  Drugs       Date:  1990-06       Impact factor: 9.546

Review 8.  Ischemic myocardial cell protection conferred by the opening of ATP-sensitive potassium channels.

Authors:  I Cavero; Y Djellas; J M Guillon
Journal:  Cardiovasc Drugs Ther       Date:  1995-03       Impact factor: 3.727

Review 9.  Mitochondria as a drug target in ischemic heart disease and cardiomyopathy.

Authors:  Andrew M Walters; George A Porter; Paul S Brookes
Journal:  Circ Res       Date:  2012-10-12       Impact factor: 17.367

10.  Identification and properties of an ATP-sensitive K+ current in rabbit sino-atrial node pacemaker cells.

Authors:  X Han; P E Light; W R Giles; R J French
Journal:  J Physiol       Date:  1996-01-15       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.